Impairments in motor automaticity cause patients with Parkinson's disease to rely on attentional resources during gait, resulting in greater motor variability and a higher risk of falls. Although dopaminergic circuitry is known to play an important role in motor automaticity, little evidence exists on the neural mechanisms underlying the breakdown of locomotor automaticity in Parkinson's disease. This impedes clinical management and is in great part due to mobility restrictions that accompany the neuroimaging of gait. This study therefore utilized a virtual reality gait paradigm in conjunction with functional MRI to investigate the role of dopaminergic medication on lower limb motor automaticity in 23 patients with Parkinson's disease that were measured both on and off dopaminergic medication. Participants either operated foot pedals to navigate a corridor ('walk' condition) or watched the screen while a researcher operated the paradigm from outside the scanner ('watch' condition), a setting that controlled for the non-motor aspects of the task.
A B S T R A C T Impairments in motor automaticity cause patients with Parkinson's disease to rely on attentional resources during gait, resulting in greater motor variability and a higher risk of falls. Although dopaminergic circuitry is known to play an important role in motor automaticity, little evidence exists on the neural mechanisms underlying the breakdown of locomotor automaticity in Parkinson's disease. This impedes clinical management and is in great part due to mobility restrictions that accompany the neuroimaging of gait. This study therefore utilized a virtual reality gait paradigm in conjunction with functional MRI to investigate the role of dopaminergic medication on lower limb motor automaticity in 23 patients with Parkinson's disease that were measured both on and off dopaminergic medication. Participants either operated foot pedals to navigate a corridor ('walk' condition) or watched the screen while a researcher operated the paradigm from outside the scanner ('watch' condition), a setting that controlled for the non-motor aspects of the task.
Step time variability during walk was used as a surrogate measure for motor automaticity (where higher variability equates to reduced automaticity), and patients demonstrated a predicted increase in step time variability during the dopaminergic "off" state. During the "off" state, subjects showed an increased blood oxygen level-dependent response in the bilateral orbitofrontal cortices (walk > watch). To estimate step time variability, a parametric modulator was designed that allowed for the examination of brain regions associated with periods of decreased automaticity. This analysis showed that patients on dopaminergic medication recruited the cerebellum during periods of increasing variability, whereas patients off medication instead relied upon cortical regions implicated in cognitive control. Finally, a task-based functional connectivity analysis was conducted to examine the manner in which dopamine modulates large-scale network interactions during gait. A main effect of medication was found for functional connectivity within an attentional motor network and a significant condition by medication interaction for functional connectivity was found within the striatum. Furthermore, functional connectivity within the striatum correlated strongly with increasing step time variability during walk in the off state (r=0.616, p=0.002), but not in the on state (r=−0.233, p=0.284). Post-hoc analyses revealed that functional connectivity in the dopamine depleted state within an orbitofrontal-striatal limbic circuit was correlated with worse step time variability (r=0.653, p < 0.001). Overall, this study demonstrates that dopamine ameliorates gait automaticity in Parkinson's disease by altering striatal, limbic and cerebellar processing, thereby informing future therapeutic avenues for gait and falls prevention.
Introduction
Impairments in motor automaticity are a hallmark feature of Parkinson's disease that cause patients to increasingly demand cortical resources in order to execute basic motor operations via attentional processes (Bohnen and Jahn, 2013; Wu et al., 2015) . A reduction in motor automaticity is of particular concern during gait in Parkinson's disease, as the cortical resources that would be used for compensation are not optimized for the fast and parallel processing required during locomotion (Clark, 2015) . Furthermore, the excessive attentional demand of walking in Parkinson's disease demands a high computational cost and interferes with gait control in conditions of high workload (Schneider and Chein, 2003; Lewis and Barker, 2009; Lewis and Shine, 2014; Clark, 2015; Wu et al., 2015) . As a result, patients with Parkinson's disease have a greater risk of adverse mobility outcomes and falls, especially during more complex everyday situations where a secondary task is performed in parallel with gait (Schaafsma et al., 2003; Clark, 2015; Hausdorff et al., 2003a; Vandenbossche et al., 2012; Lewis and Shine, 2014; Strouwen et al., 2015; Wu et al., 2015) . Despite the clinical importance of gait in Parkinson's disease, the precise neural mechanisms underlying impairments in locomotor automaticity remain poorly understood, thus impeding targeted management (Wu et al., 2015) .
Increased step time variability is a robust predictor for falls in Parkinson's disease (Hausdorff et al., 1998) and has previously been suggested as a surrogate measure for reduced locomotor automaticity (Frenkel-Toledo et al., 2005; Yogev et al., 2005; Peterson and Horak, 2016) . A recently proposed framework by Wu and colleagues (2015) outlines several features that indicate whether a motor deficit is directly linked to an underlying impairment in motor automaticity in Parkinson's disease, namely: i) the motor skill is performed automatically (and without behavioural interference) in healthy subjects; ii) dual task performance results in significant deterioration in the motor skill in patients with Parkinson's disease as compared to healthy subjects; and iii) external cueing (or attention) significantly improves the performance of this motor skill (Wu et al., 2015) . If this theoretical model is applied to the existing literature, it indeed becomes evident that step time variability fits these criteria as an index of locomotor automaticity: i) stride time variability is resistant to interference during dual-task walking in healthy subjects (Yogev et al., 2005) , suggesting that regulation of stride time variability is an automated motor skill in healthy subjects (Friedman et al., 1982; Yogev et al., 2005; Wu et al., 2015) ; ii) in Parkinson's disease, walking while performing a cognitive dual task exacerbates stride time variability (Hausdorff et al., 2003b; Yogev et al., 2005; Plotnik et al., 2011) and patients experience higher dual task cost during walking as compared to healthy subjects (Yogev et al., 2005) ; iii) stride time variability in Parkinson's disease has been shown to reduce in the presence of external auditory cues (Willems et al., 2006; Hausdorff et al., 2007; Rochester et al., 2011) . Therefore, this evidence suggests that step time variability, the regulation of which is an automated process in the healthy population, is impaired in Parkinson's disease and reflective of reduced motor automaticity (Yogev et al., 2005; Bohnen and Jahn, 2013; Lewis and Shine, 2014; Wu et al., 2015; Peterson and Horak, 2016) .
Motor automaticity is typically achieved through motor learning, followed by the timely initiation and maintenance of automated motor sequences, even during interference (Wu et al., 2015) . During motor learning, the posterior striatum (putamen) is thought to 'chunk' motor action sequences under the influence of dopamine (Graybiel, 1998) . This process allows performance of well-learned motor patterns to be executed as a single unit of activity rather than multiple serial computations, enhancing neural efficiency and reducing motor variability (Schneider and Chein, 2003; Poldrack et al., 2005; Wymbs et al., 2012; Wu et al., 2015) . The initiation of an automatic sequence is thought to involve a shift from the anterior associative fronto-striatal circuit to the posterior sensorimotor striatum (Miyachi et al., 1997; Lehéricy et al., 2005; Wymbs et al., 2012; Wu et al., 2015) , which frees up frontal attentional resources that can then be used to process concurrent secondary demands (Carbon and Marié, 2003; Monchi et al., 2007; Lewis and Shine, 2014; Wu et al., 2015) . The most well described circuits involved with maintaining an automated motor sequence include the spinal cord, brainstem locomotor regions, posterior striatum, primary cortical motor regions and cerebellum ( Fig. 1 ) (Poldrack et al., 2005; Bohnen and Jahn, 2013; Clark, 2015; Wu et al., 2015) . Doyon et al. (2002) further proposed that during motor learning, a transfer of experience-dependent changes from the cerebellar cortex to the deep cerebellar dentate nucleus takes place, and then with extended practice, from a cerebellar-cortical to a striatalcortical network (Doyon et al., 2002) . Evidently, a well functioning striatum is integral for effective locomotor automaticity (Wu et al., 2015) .
Ascending dopaminergic neurons in the midbrain provide rich innervation to the entire striatum, thereby exerting neuromodulatory control over information processing across the striatum and parallel cortico-striatal loops that underpin the execution of coordinated behaviours (Alexander et al., 1986; Kelly et al., 2009; Helmich et al., 2010; Surmeier et al., 2010; Hacker et al., 2012; Sharman et al., 2013; Bell et al., 2014) . In Parkinson's disease, the pathological degeneration of nigrostriatal dopaminergic neurons impacts on the communication across the striatum and parallel cortico-striatal circuits (Alexander et al., 1986; Kelly et al., 2009; Helmich et al., 2010; Surmeier et al., 2010; Hacker et al., 2012; Sharman et al., 2013; Bell et al., 2014) , Fig. 1 . Schematic representation of the locomotor automaticity processes in health and hypothesized neural mechanisms underlying automaticity impairments in Parkinson's disease with and without dopaminergic replacement therapy. Left image -hypothesized posterior motor network underlying locomotor automaticity in health; Middle image -dopaminergic pathology in posterior striatum in Parkinson's disease is thought to cause patients to utilize attention demanding cortical resources to operate gait; Right image -dopaminergic replacement therapy is thought to normalize locomotor automaticity impairments in Parkinson's disease. NOTE: "Off"=Dopamine depleted state; "On"=On dopaminergic replacement therapy.
which likely impairs motor learning and automaticity ( Fig. 1 ) (Vandenbossche et al., 2012; Bohnen and Jahn, 2013; Lewis and Shine, 2014; Hamacher et al., 2015; Wu et al., 2015; Peterson and Horak, 2016) . Indeed, the dopaminergic insult is most severe in the posterior striatum (i.e. sensorimotor putamen) that is involved with motor learning and automaticity (Brooks et al., 1990; Poldrack et al., 2005; Wu et al., 2015) . Furthermore, step time variability improves with dopaminergic replacement therapies in Parkinson's disease (Fig. 1 ) (Hausdorff et al., 2003a; Schaafsma et al., 2003; Bryant et al., 2016) . The dopamine depletion in the posterior putamen is also likely to impact on the anterior-to-posterior striatal shift (Ashby et al., 2010; Everitt and Robbins, 2016) , thus placing additional load on the frontal attentional resources that further prevents patients from effectively utilizing compensatory locomotor control strategies when automaticity is reduced (Lewis and Barker, 2009; Helmich et al., 2010; Vandenbossche et al., 2012; Lewis and Shine, 2014; Wu et al., 2015) . Finally, it has often been suggested that Parkinson's patients utilize the cortico-cerebellar pathways involved during early motor learning in order to maintain motor functions following the cortico-striatal impairments (Hanakawa et al., 1999; Wu and Hallett, 2013; Peterson and Horak, 2016) . However, to date little evidence exists describing the neural mechanisms underlying deficits in locomotor automaticity and the role of compensatory strategies in Parkinson's disease due in great part to the mobility restrictions that accompany the neuroimaging of gait per se (Shine et al., 2013a; Wu et al., 2015) . As such, we currently lack a precise understanding of how dopaminergic pathology impairs motor automaticity during gait (Vandenbossche et al., 2012; Bohnen and Jahn, 2013; Lewis and Shine, 2014; Hamacher et al., 2015; Wu et al., 2015; Peterson and Horak, 2016) . Furthermore, the role of dopaminergic medication in regulating locomotor automaticity in Parkinson's disease remains poorly understood. Finally, understanding compensatory mechanisms for overcoming locomotor automaticity impairments in Parkinson's disease remains an important unresolved clinical question (Nonnekes et al., 2015; Wu et al., 2015; Peterson and Horak, 2016) .
In this study we set out to investigate the neural mechanisms of dopamine on repetitive lower limb movements in Parkinson's disease. Twenty-three patients with Parkinson's disease performed a virtual reality gait paradigm in conjunction with functional MRI both on and off their dopaminergic medication. The virtual reality task required patients to either operate foot pedals to navigate a virtual corridor (walk condition) or to watch the screen while a researcher operated the paradigm from outside the scanner (watch condition). We hypothesized that in the off medication state, patients with Parkinson's disease would show increased variability in their step times as compared to the medicated state, indicative of reduced motor automaticity (Hausdorff et al., 2003b; Yogev et al., 2005; Gilat et al., 2013) . We further hypothesized that this increase in variability would be associated with increased Blood Oxygenation Level Dependent (BOLD) in frontal and parietal cortical regions that are associated with the attentional control of movements (Ouchi et al., 2001; Bohnen and Jahn, 2013; Wu et al., 2011; Peterson and Horak, 2016) . In addition, a recent resting state functional MRI study showed that the strength of connectivity across the striatum was significantly reduced in Parkinson patients off their dopaminergic medication, which even at rest impacted on largescale sensorimotor network dynamics (Bell et al., 2014) . As such, we hypothesized that dopamine denervation would also have the strongest effect on the connectivity across the striatum during the virtual gait task (Bell et al., 2014) , as shown by a significant condition (watch, walk) by medication (off, on) interaction effect. Furthermore, we hypothesized that dopamine depleted connectivity changes across the striatum would correlate with increasing step time variability (Hausdorff et al., 2003a; Schaafsma et al., 2003 Bryant et al., 2016 and impact on the connectivity across large-scale motor automaticity and attentional motor control networks involved with gait in Parkinson's disease (Kelly et 
Materials and methods

Study protocol
Twenty-three patients with Parkinson's disease that satisfied the United Kingdom Parkinson's Disease Society Brain Bank clinical diagnostic criteria were recruited for this study from the Parkinson's Disease Research Clinic, Brain and Mind Centre, The University of Sydney. None of the patients were diagnosed with dementia according to the Movement Disorders Society guidelines (Goetz et al., 2008) or major depression according to Diagnostic and Statistical Manual of Mental Disorders-IV guidelines of the American Psychiatric Association (Diagnostic and Statistical Manual of Mental Disorders (4th ed., text rev.)). None of the participants had any additional neurological comorbidities including no history of stroke or significant head injury. In addition, high-resolution T1-weighted images of each subject passed visual inspection by an experienced radiologist for absence of any pathological white or grey matter lesions. All patients received dopamine-replacement therapy as part of their daily clinical management. Specifically, twelve patients were on levodopa monotherapy; two patients were on dopamine agonist monotherapy; four patients were on levodopa plus a dopamine agonist; two patients were on levodopa plus a monoamine oxidase inhibitor; three patients were on levodopa plus a dopamine agonist plus a monoamine oxidase inhibitor. Patients were tested on two separate occasions, once whilst on their usual medications and once in the practically defined off state, having been withdrawn from their dopaminergic medication overnight for more than 12 h before testing. The order of testing (ON/OFF) was randomized and counterbalanced between subjects with a minimum interval of three weeks between trials (mean: 7.4±5 weeks).
In addition to PD participants, we also acquired imaging data in an independent group of twelve healthy age matched control participants (see Materials and methods: Regions of interest) that were scanned on a single occasion. The acquisition of healthy control data enabled datadriven functional localization of regions involved in lower limb motor control during the virtual gait paradigm in an independent and matched cohort. Ethical approval for this study was obtained from the University of Sydney Human Research Ethics Committee and written informed consent was obtained from each subject in accordance with the Declaration of Helsinki.
Cognitive and neurological assessment
All subjects were assessed on the Mini Mental State Examination. In addition, the motor section of the Movement Disorders Society Unified Parkinson's Disease Rating Scale (UPDRS-III) and the Hoehn and Yahr Stages (HY), both on and off medications were obtained from patients with Parkinson disease. Motor symptom severity was assessed per body side by calculating a sum score of the UPDRS-III items for the left and right body side separately (items 3.3-3.8 and 3.15-3.17) . The body side with the highest sum score on these UPDRS-III items was defined as being most affected. Furthermore, item 3 of the Freezing of Gait Questionnaire (FOG-Q3) "Do you feel that your feet get glued to the floor while walking, making a turn or when trying to initiate walking (freezing)?" was obtained from each subject. Finally, dopamine dose equivalency scores were recorded. Cognitive and neurological measures were compared between medication states using a pairedsamples t-test or non-parametric Wilcoxon Signed Rank Sum test (alpha=0.05).
Virtual reality task
The virtual reality task was performed while subjects lay supine inside the MRI scanner. The duration of the task was 10 min. The task stimuli were presented on a screen that could be clearly viewed via a mirror mounted onto the head coil. The virtual environment consisted of a straight corridor presented in the first person that contained no additional environmentally salient or cognitive triggers, which have previously been utilised to trigger freezing behaviour (motor arrest) ( Fig. 2A) (Shine et al., 2013a; Gilat et al., 2013; . Indeed very little behavioural freezing (less than 0.05% of the total paradigm) was observed in the current experiment. Progression through this corridor was accomplished by alternately depressing left and right foot pedals at least 30°below parallel in a physiological sequence (e.g. left-right-left-…). Out of sequence steps (left-left or right-right) did not result in forward progression and were disregarded from behavioural analyses. Subjects were instructed to tap the pedals in a comfortable rhythm as per previous work (Shine et al., 2013a; Gilat et al., 2013; . The paradigm was made up of alternating blocks that instructed the participants to perform either of two rules. Walk blocks were initiated with the word "WALK" being presented on screen instructing the participants to start operating the pedals. In addition, participants performed a control watch block. Watch blocks were initiated with the word "WATCH" being presented on screen instructing participants to refrain from operating the pedals and watch the screen while a researcher operated the task from outside the MRI scanner in a similar rhythm as the participants. Subjects were therefore presented with the same visual input and baseline cognitive and limbic processes as during walk, without the need for any motor activation of the legs. Each block lasted for approximately one minute depending on the subject's latency and was ended when the word "STOP" was presented on screen in the colour red. Six seconds after participants had stopped accordingly, the alternative of the previous instruction (either "WALK" or "WATCH") was presented. Each participant completed 4-5 alternating blocks of both conditions with the first condition always being a walk block to allow the researcher to ensure that the patient had understood the instructions.
Behavioural measures
Footstep latency was calculated during walk by measuring the time between two consecutive foot pedal depressions. The first five steps following a "WALK" cue and any step following a "STOP" cue were excluded from the analyses to remove the effects of motor initiation and cessation (Georgiades et al., 2016) . The mean and standard deviation were then used to calculate the coefficient of variation, which is a measure of step time variability (Hausdorff et al., 2003a; Gilat et al., 2013) . A coefficient of variation in footstep latencies was also calculated for each foot separately. A repeated measures ANOVA was then used to investigate the interaction between medication (off, on) and symptom side (most affected, least affected) on the coefficient of variation for each leg separately. In addition, the coefficient of variation was compared between the most-and least affected side using a pairedsampled t-test for both medication states. These analyses were performed to assess whether any increase in variability may be confounded by asymmetry in symptom severity. No behavioural measures were obtained during watch blocks, however all participants responded adequately to the "WALK" cue that followed a watch block ( < 2 s initiation times), indicating that they were likely to be paying close attention to the task.
Neuroimaging Image acquisition
A General Electric 3T MRI was used to obtain T 2 *-weighted echo planar functional images in sequential order with repetition time (TR) =3 s, echo time=32ms, flip angle=90°, 32 axial slices covering the whole brain, field of view=220 mm, interslice gap=0.4 mm and raw voxel size=3.9 mm×3.9 mm×4 mm thick. High-resolution 3D T1-weighted anatomical images with voxel size=0.4×0.4×0.9 mm were obtained for co-registration with functional scans.
Image pre-processing
Image processing and analyses were performed using Statistical Parametric Mapping Software (SPM12, Wellcome Trust Centre for Neuroimaging, London, UK). Functional images were pre-processed using the standard pre-processing pipeline provided with SPM12. Functional scans were: (i) manually realigned along the anteriorposterior commissure; (ii) slice-time corrected to the median (17th) slice in each scan; (iii) realigned to create a mean realigned image and measures of 6 degrees of rigid head movements were created for later use in the correction of minor head movements; (iv) unwarped to deal with residual movement related variance induced by the susceptibilityby-movement interaction effects; (v) spatially normalized using the T 1 -weighted image to improve segmentation accuracy; (vi) co-registered and estimated; and (vii) smoothed using an 8-mm full-width at half maximum isotropic Gaussian kernel. Spatial normalization was then manually checked for quality assurance.
Head motion correction
Multiple precautions were taken to ensure head motion was fully accounted for: (i) all subjects were instructed to minimize head motion by only moving the ankles, while not raising the legs and restrict hip rotation; (ii) cushions were placed inside the head coil to ensure optimal performance with the least amount of head motion; (iii) following data collection, trials with > 3 mm or 3°of scan-to-scan movement were considered a-priori exclusion criterion; (iv) six motion and nuisance regressors were added into the first level analysis per subject, controlling for minor movement artefacts in the three directions of translation and axes of rotation; (v) each trial was analysed using ArtRepair (Mazaika et al., 2007) and trials with a large amount of global drift or scan-to-scan head movement > 1.5 mm were corrected using the interpolation method; and finally, (vi) mean frame-wise displacement was calculated per trial and compared across sessions, showing no significant differences between the on and off states (Parkinson patients off versus on: Z=−0.304, p=0.761) or between groups (Parkinson patients off versus controls: U=124, Z=−0.487, p=0.644; Parkinson patients on versus controls: U=126, Z=−0.417, p=0.694).
Event related whole brain analysis
Individual first-level spatial maps were created in SPM12 using a general linear model analysis within an epoch-related design in a fixedeffects analysis. A design matrix was created for each subject by entering two regressors for each trial: a regressor that modelled the specific onset times and associated temporal derivatives of walk blocks and a regressor that similarly modelled the watch blocks. Contrast images from the first-level analyses were then entered into a secondlevel random-effects dependent samples t-test design to test the effects of dopaminergic medication within the Parkinson's disease group on the condition of interest (walk > watch), whereas a one-sample t-test design was used for the healthy control group. To further investigate imaging-behaviour associations, 8mm ROIs were created around the peak voxel for each significant second-level cluster found when contrasting walk > watch between medication states in Parkinson's disease.
In addition, a whole brain parametric modulation analysis was used to investigate which brain regions were involved in the modulation of step time variability. First, a normalized footstep variability value per TR was calculated for the walk blocks for each subject. The normalized footstep variability was calculated as an absolute Z-score of footstep latencies, which were then de-meaned and averaged per TR. This parametric modulator vector was then entered into a general linear model together with the six head motion regressors and time derivatives of the hemodynamic response function in the first level analysis of SPM12. Contrast images from this analysis were then entered into a second-level random-effects analysis: dependent samples t-test to investigate differences between dopaminergic states in the Parkinson's disease group; and one-sample t-test analysis for the healthy control group. Regions with a negative relationship to the parametric modulator were associated with maintaining low step time variability, whereas an increased BOLD response indicates that those regions were involved during period of increasing step time variability, and hence, worsened automaticity.
The whole brain voxel maps for both analyses were displayed using xjView (www.alivelearn.net/xjview) software (p < 0.005, k > 20) (Lieberman and Cunningham, 2009 ) and a threshold-free cluster enhancement (TFCE) for multiple corrections was performed on each second level contrast (Smith and Nichols, 2009) . To explore the direction of pattern in the BOLD responses found in this study, significant clusters (See Supplementary Table 3 for MNI coordinates) from the within-Parkinson group second level T-maps were saved as images and raw Beta scores were then extracted from these ROIs using the MarsBar toolbox (Brett et al., 2002) in SPM12, the values of which were averaged for reporting purposes only.
Task-based functional connectivity
In this analysis, we examined the effect of dopaminergic medication on large-scale network interactions within and between motor automaticity, attentional motor control and striatal networks. Task based functional connectivity in these networks was calculated using predefined regions of interest (ROI) as further described below. The Response Exploration for Neuroimaging datasets toolbox (Duff et al., 2007) was used to extract time series data of each predefined ROI for each patient. Task-based functional connectivity was then calculated using the Multiplication of Temporal Derivatives statistical method . This method allows greater temporal resolution of time-resolved connectivity in BOLD time series data when compared to the conventional sliding-window Pearson's correlation coefficient . The code is freely available at http:// github.com/macshine/coupling/ . First, mean functional connectivity was calculated within and between each network of interest and entered into condition (watch, walk) by medication (on, off) repeated measures ANOVAs (alpha=0.05, False Discovery Rate (FDR) correction 0.05). For significant interactions post-hoc correlations were performed to further examine whether the task-based functional connectivity was associated with worse step time variability. Furthermore, to examine whether striatal dopamine modulated the communication across large-scale networks, we further examined the effects of dopamine on internal network connectivity. A correlation analysis was performed on the amount of functional connectivity during walk in the on state compared to the off state (on-off) for the connectivity across each network.
Regions of interest
Regions of interest were defined using a combination of data-driven regions identified using the age-matched healthy control group during performance of the virtual gait task and pre-defined a priori regions shown to be involved in attentional motor control in Parkinson's disease and the striatum (see Supplementary Materials: Regions of interest for full description). Defined regions of interest were then utilized for subsequent functional connectivity analyses (see Supplementary Table 2 for MNI coordinates). These regions composed three different networks: motor automaticity, attention motor and striatal networks.
Motor automaticity network
As it is currently unclear how lower limb motor automaticity is achieved, data from the twelve matched healthy control subjects was used to explore which brain regions would be involved with the performance of the virtual reality task (walk > watch), and specifically to identify which brain regions would be associated with maintaining low step time variability. Based on this data-driven approach we included the bilateral primary motor cortex area of the legs, thalamus, putamen, superior orbitofrontal gyrus, lateral cerebellum and anterior cingulate into the motor automaticity network. In addition, the cerebellar locomotor and bilateral mesencephalic locomotor regions were included as predefined a-priori regions of interest (See Supplementary Materials: Regions of interest and Supplementary  Tables 1 and 2 for MNI coordinates).
Attention motor network
The low variability in step times seen in the healthy control participants did not allow for the investigation of the attention demanding cortical regions that are hypothesized to be associated with Peterson and Horak, 2016). As such, predefined ROIs were created for regions that have been shown to be involved with the attentional control of movements in Parkinson's disease, including the dorsal lateral prefrontal cortex (DLPFC), pre-supplementary motor area (pre-SMA), dorsal premotor cortex (PMd) and posterior parietal cortex (PPC) (Cole and Schneider, 2007; Kurz et al., 2012; Shine, et al., 2013b; Wu et al., 2011; .
Striatal network
The striatal network consisted of seven predefined regions of interest in the striatum of each hemisphere in the Parkinson's disease group, as described by Bell et al. (2014) . These striatal regions correspond to dissociable functional systems (Di Martino et al., 2008; Kelly et al., 2009 ) and enable broad coverage of the striatum (Bell et al., 2014) . The ROIs included the bilateral: inferior ventral striatum (VSi), superior ventral striatum (VSs), dorsal caudate (DC), dorsal caudal putamen (DCP), dorsal rostral putamen (DRP), ventral rostral putamen (VRP) and postcommissural putamen (PCP) (Di Martino et al., 2008; Kelly et al., 2009; Bell et al., 2014) . Based on the study by Di Martino and colleagues (2008) we further defined the caudal putamen seeds (DCP and PCP) as being most involved with sensorimotor tasks, the dorsal caudate (DC) with cognitive control and the inferior ventral striatum (VSi) seeds, which approximate the nucleus accumbens, with limbic processing (Di Martino et al., 2008) . These seeds were used to define striatal cognitive-motor, limbic-motor and limbic-cognitive connections during a post-hoc analysis, as further described below.
Results
Participant demographics and behavioural outcomes
Patients with Parkinson disease and healthy control subjects were matched across multiple demographics (see Supplementary Table 4 ). The Parkinson's disease patients had a mean levodopa equivalent daily dose of 861 (±525) and disease duration (in years) of 6 (±2.9). Patients demonstrated clinical improvement following dopaminergic treatment, as indicated by a significantly lower UPDRS-III score and HY stages in the on state (Table 1) . The current cohort consisted of patients with a range of freezing of gait severity, with eight subjects scoring a 0 ('Never'), six subjects scoring a 1 ('Very rarely') and nine subjects scoring > 1 ('Rarely-Often-Always') on the FOG-Q3. Importantly, Parkinson's disease patients off medication had similar modal footstep latencies as compared to when medicated, which together with similar scores on UPDRS-III items 3.7 (toe tapping) indicate that any group differences found were unlikely to be driven by an overall difference in lower limb motor performance (e.g. rigidity) ( Table 1) . However as predicted, step time variability was significantly higher in Parkinson patients off their medication as compared to when on medication (Table 1) , suggesting between group differences in motor automaticity. Indeed, no significant interaction effect was found between medication (off, on) and symptom side severity (most affected, least affected) on the coefficient of variation of footstep latencies (F=0.992, p=0.330 ). This analysis also revealed no main effect of medication (F=2.698, p=0.115) or main effect of symptom side severity (F=0.598, p=0.448). Furthermore, a difference score in toe tapping ability between the most-and least affected side did not significantly correlate with the coefficient of variation in footstep latencies in either medication state (Spearman correlation OFF: ρ=0.318, p=0.139; ON: ρ=−0.311, p=0.149). Together, these results indicate that the change in step time variability seen between medication states did not reflect asymmetry in symptom severity.
Neuroimaging results
Whole brain activation (walk > watch)
The dopamine-depleted state of Parkinson's disease was associated with a significantly positive BOLD response in the bilateral orbitofrontal cortex during walk compared to negative BOLD during watch (TFCE corrected, see Fig. 2B and Supplementary Table 3 for peak voxel coordinates). In addition, within-group analysis revealed that in both medication states patients demonstrated activation of the primary motor cortex. However, when on medication patients also utilized the pre-supplementary motor area, visual cortex and cerebellum, whereas patients off medication utilized the right mid frontal gyrus and bilateral orbitofrontal cortex (see Supplementary Fig. 2 ). For exploration (i.e. non-statistical) purposes only, post-hoc one-sampled and pairedsampled t-tests were performed on the mean beta values in the orbitofrontal clusters that were found to be significantly different between medication states on the condition of interest (walk > watch) (See Fig. 2C ). These results confirmed that in the off state, the beta values in the orbitofrontal clusters were significantly different from zero during both walk and watch blocks (all p < 0.01, Bonferonni corrected) and significantly different between walk and watch blocks (Left orbitofrontal: t=4.36, p < 0.001; Right orbitofrontal: t=5.42, p < 0.001, Bonferonni corrected). No differences in beta values were found for both orbitofrontal clusters in the dopaminergic on state between walk and watch blocks (Left orbitofrontal: t=0.560, p=0.592; Right orbitofrontal: t=0.881, p=0.151), which were also not significantly different from zero (all p > 0.1).
Whole brain activation (parametric modulator)
The goal of this analysis was to identify regions that were consistently associated with greater step time variability. The BOLD responses associated with the parametric modulator in the Parkinson's disease group are presented in Fig. 3 . In the off state Parkinson's disease patients had significant negatively signed beta values across the right dorsal premotor cortex and left posterior parietal cortex in contrast to the slight positively signed beta values in these regions in the on state ( Fig. 3C and E) . This suggests that a negative association exists between BOLD response in these regions and step time variability in the off state. Furthermore, patients on medication had significant positively signed beta values in the right lateral cerebellum compared to the off state ( Fig. 3C and E) , indicating that the cerebellar regions were recruited during periods of increasing step time variability when medicated, although these findings did not survive TFCE correction for multiple comparisons. As tremor amplitude in Parkinson's disease has previously been associated with increased beta values in the cerebellum (Helmich et al., 2012) , a post-hoc Spearman correlation analysis was performed between the sum score of UPDRS-III tremor items 3.15-3.18 and the beta weights of the right cerebellum cluster found to be significantly associated with the parametric modulator. The results showed no significant correlations between tremor scores and cerebellar Beta weights for both medication states (OFF: ρ=0.199, p=0.362; ON: ρ=0.142, p=0.517), indicating that tremor was unlikely to explain the results found. To explore whether Parkinson patients utilized a cortico-cerebellar network in order to operate movements as a compensation for corticostriatal impairments (Rascol et al., 1997; Doyon et al., 2002) , a posthoc correlation analysis was performed between the loading of the parametric modulator regressor onto the right lateral cerebellum that was found to be significant during the parametric modulator analysis contrast (OFF > ON, see Fig. 3C ) and the functional connectivity within the attention motor control network. A positive correlation was found between the loading of the variability regressor onto the right lateral cerebellum and the total functional connectivity within the regions of the cognitive network for the Parkinson's disease group when off medication (r=0.452, p=0.030, uncorrected), whereas the negative correlation found when patients were medicated did not reach statistical significance (r=−0.246, p=0.259) (Fig. 3F) .
Task-based functional connectivity
As predicted a significant main effect of condition was found for all network connections showing an increased functional connectivity during walk as compared to watch (see Supplementary Fig. 3 , FDR corrected). Furthermore, a significant main effect of medication was found within the attention motor network (FDR corrected, see Fig. 4) . A significant condition (watch, walk) by medication (off, on) interaction effect was found within the striatum (F(1,22)=5.022, p=0.035, uncorrected, see Fig. 4 ). Post hoc simple effect analysis showed that patients on medication were able to increase internal functional connectivity within the striatal network during walk compared to watch (Mean difference=0.367, p=0.003, FDR corrected), whereas patients off medication were not (Mean difference=0.106, p=0.285).
To examine how striatal dopamine modulates the interactions across large-scale networks, we further examined the effects of dopamine on internal network connectivity. Results showed that dopaminergic modulation of the striatal network significantly correlated with the degree of dopaminergic modulation of internal motor automaticity network (r=0.536, p=0.008, Bonferonni corrected) and internal attention-motor network connectivity (r=0.464, p=0.026, uncorrected). As expected, there was no relationship between dopaminergic modulation of the attention-motor network and motor automaticity networks (r=0.219, p=0.315), indicating that the dopaminergic innervation of the striatum may be a key driving factor in modulating dopamine mediated change in functional connectivity in other large-scale networks.
Imaging-behaviour associations
We further examined the relationship between the major imaging findings in this study and behaviour, in order to explain how breakdown in network communication perturbs locomotor automaticity in the dopamine depleted state. Following the significant condition by medication interaction effect within the striatum, a post-hoc correlation analysis was performed between the amount of functional connectivity within the striatum during walk and step time variability (Bonferonni corrected for multiple comparisons). Internal striatal functional connectivity during walk correlated strongly with increasing step time variability in the off state (r=0.616, p=0.002), whereas no such correlation was found in the on state (r=−0.233, p=0.284). To further explore these findings, a separate post-hoc analysis was performed to see which striatal circuit (e.g. cognitive-motor, limbicmotor or limbic-cognitive) was driving this correlation with step time variability during walk (Fig. 5A-B) . Interestingly, a significant correlation was found between step time variability and the functional connectivity in the striatal limbic-motor (r=0.688, p < 0.001) and limbic-cognitive (r=0.597, p=0.003) circuits, whereas the cognitivemotor (r=0.380, p=0.068) functional connectivity did not reach statistical significance (Fig. 5A-B) . No significant correlations were found in the on state (limbic-motor: r=−0.153, p=0.487; limbiccognitive: r=−0.227, p=0.297; cognitive-motor: r=−0.142, p=0.519).
As aforementioned, the whole brain analysis comparing walk > watch between medication states revealed increased bilateral BOLD responses in the orbitofrontal cortex in the off state (see Fig. 2 ). The orbitofrontal cortex is known to have connections with multiple areas of the striatum allowing it to adapt behaviour (Haber et al., 1995; Schoenbaum et al., 2009; Rolls, 2015) . As such, to explore its influences in the current study a second post-hoc analysis was performed to investigate whether the functional connectivity between the orbitofrontal cortex (see supplementary table 3 for MNI coordinates) and intra-striatal circuits was correlated with step time variability (Fig. 5C) . The results showed that the functional connectivity between the bilateral orbitofrontal cortex and inferior ventral striatum (limbic, r=0.653, p < 0.001) and dorsal putamen seeds (motor, r=0.643, p < 0.001) were significantly correlated to step time variability in the off state (Bonferonni corrected for multiple comparisons), whereas no correlation was found between step time variability and the functional connectivity between the orbitofrontal cortex and dorsal caudate nucleus (cognitive, r=0.293, p=0.174) (Fig. 5C ). Again no significant correlations were found in the on state (motor: r=−0.323, p=0.132; cognitive: r=−0.167, p=0.447; limbic: r=−0.304, p=0.159).
Finally, it has been proposed that local depletion of dopamine levels within the striatum in Parkinson's disease can lead to a reduced ability to consecutively process information through complementary yet competing cortico-striatal neural pathways (e.g. motor, cognitive and limbic pathways), which may eventually result in the inhibition of brainstem locomotor centres (Lewis and Barker, 2009; Lewis and Shine, 2014) . We therefore wanted to explore whether the increased striatal limbic functional connectivity in Parkinson's disease patients off medication could have been influenced by a reduced ability to integrate this information into the consecutive motor or cognitive cortico-striatal pathways. As such, a post-hoc analysis was performed by correlating the degree of functional connectivity within the striatal limbic circuits (e.g. limbic-motor and limbic-cognitive) with the amount of functional connectivity between the primary motor cortex and dorsal putamen (motor cortico-striatal loop) and between the dorsolateral prefrontal cortex and dorsal caudate (cognitive corticostriatal loop) (Fig. 6A) . Results showed that during the on state, the functional connectivity in intra-striatal limbic circuits correlated strongly with the functional connectivity between regions of the cognitive cortico-striatal loop (striatal limbic-motor: r=0.615, p=0.002; striatal limbic-cognitive: r=0.711, p < 0.001), but not the motor cortico-striatal loop (striatal limbic-motor: r=−0.125, p=0.569, limbic-cognitive: r=0.204, p=0.351) (Fig. 6B-C) . Interestingly, no significant correlations were found in the off medication state for either the cognitive cortico-striatal loop (striatal limbic-motor: r=−0.189, p=0.387; limbic-cognitive: r=0.077, p=0.728) or the motor cortico-striatal loop (striatal limbic-motor: r=0.080, p=0.718; limbiccognitive: r=0.074, p=0.738).
Discussion
To our knowledge, this is the first study to investigate the role of dopamine on the neural mechanisms underlying lower limb motor automaticity impairments in Parkinson's disease. Twenty-three patients with Parkinson's disease performed an interactive virtual reality paradigm consisting of two conditions (walk, watch) in conjunction with functional MRI both on and off dopaminergic medication. The main results were: (i) Parkinson's disease patients had greater step time variability off dopaminergic medication and recruited the bilateral orbitofrontal cortex when performing lower limb movements in the virtual reality task, as compared to when appropriately medicated; (ii) in the dopamine-depleted "off" state, patients with Parkinson's disease demonstrated an over-reliance on regions associated with cognitive Fig. 5 . Post-hoc correlation analysis between functional connectivity in limbic circuits and step time variability during the walk condition of the virtual reality task in Parkinson's disease patients off their dopaminergic medication. A=Representation of the limbic intra-striatal and orbitofrontal-striatal functional connections; B=Scatter plots for the correlation analyses between functional connectivity in the intra-striatal limbic circuits and step time variability; C=Scatter plots for the correlation analyses between functional connectivity in the orbitofrontal-striatal limbic circuits and step time variability. NOTE: PD OFF=Parkinson's disease patients off their dopaminergic replacement medication (n=23);
Step time variability measured as the coefficient of variation in footstep latencies; DC=Dorsal Caudate; DCP=Dorsal Caudal Putamen; VSi=Inferior Ventral Striatum; OFC=Orbitofrontal Cortex; CV=Coefficient of Variation; *Indicates a significant p-value (p < 0.05) that survived Bonferonni correction for multiple comparisons.
control, which is in contrast to the recruitment of the cerebellum to maintain low variability in the "on" state; (iii) dopamine had a demonstrable influence on intra-striatal functional connectivity during lower limb movements; (iv) in the dopamine depleted-state, functional connectivity in orbitofrontal-striatal limbic circuits was correlated with step time variability; (v) with the administration of dopamine, the aforementioned striatal limbic circuits became coupled with cognitive cortico-striatal pathways that are putatively used to integrate the limbic information in order to maintain effective motor performance.
As predicted, patients with Parkinson's disease demonstrated an increased step time variability during the virtual reality gait task in the dopamine depleted state compared to when medicated, indicative of a loss of motor automaticity (Hausdorff 2003b; Yogev et al., 2005; Plotnik et al., 2011; Kelly et al., 2012; Gilat et al., 2013) . This finding is in accordance with a broad literature showing that dopaminergic medication improves step time variability during over ground walking in Parkinson's disease (Hausdorff et al., 2003b; Schaafsma et al., 2003; Bryant et al., 2016) and is thought to indicate a shift from an automated towards a more attention demanding cognitive strategy of motor control (Bohnen and Jahn, 2013; Clark, 2015; Peterson and Horak, 2016) .
During the walk condition, patients with Parkinson's disease in the dopamine depleted state demonstrated significantly greater BOLD activation across the bilateral orbitofrontal cortex compared to the on state (TFCE corrected). The orbitofrontal cortex is involved in many functions including modulation of attention and goal-directed behaviour (Rolls and Grabenhorst, 2008; Lewis and Barker, 2009; Takahashi et al., 2011; Hartikainen et al., 2012; Marinelli et al., 2015) . These findings are in accordance with Ouchi et al. (2001) who used dopamine transporter PET imaging (DAT and [11C] CFT) to show that Parkinson's disease patients off their medication have significantly increased activation in dopaminergic neurons of the bilateral orbitofrontal cortices during continuous straight walking, whereas gait in healthy controls activated the dopaminergic neurons in the putamen (Ouchi et al., 2001) . Importantly, orbitofrontal [11C] CFT uptake in Parkinson's disease was inversely correlated with cadence during gait (Ouchi et al., 2001 ).
The novel parametric modulator analysis used in the current study showed that during periods of increasing variability Parkinson's disease patients on medication engaged the bilateral cerebellum, a key hub known to be important for automated feed-forward control of motor timing and adaptation (Rand et al., 1998; Lang and Bastian, 1999; Doya, 2000; Morton and Bastian, 2006; Wu and Hallett, 2013) . Recruiting this region may have allowed patients on medication to appropriately adapt to sudden changes in step timing variability without the need for attentional control (Horak and Diener, 1994; Rand et al., 1998; Doya, 2000; Morton and Bastian, 2006) Without dopaminergic medication however, the same patients became unable to recruit the cerebellum and instead relied on cortical regions associated with cognitive control. The slow and serial processing of these cognitive resources (Schneider and Chein, 2003) could have required a longer time for peripheral information to be integrated with the stepping pattern resulting in a higher step time variability (Lucas et al., 2013; Shine, et al., 2013a; Clark, 2015; Hamacher et al., 2015) . These results however did not survive TFCE correction for multiple comparisons, warranting cautious interpretation.
A post-hoc analysis further showed that the loading of the variability regressor onto the cerebellum correlated significantly with the amount of functional connectivity within the attentional motor network in the off state. This novel finding could reflect a compensatory increase in network level organization where the attentional motor network might be attempting to engage the cerebellum following a loss of motor automaticity in the striatum (Wu et al., 2009; , although seemingly failing to do so. As the cerebellum receives relatively minor dopaminergic innervation (localized mostly in the vermis) (Melchitzky and Lewis, 2000) but shares strong reciprocal connections to the basal ganglia (Morton and Bastian, 2004; Bostan et al., 2013) , it could be through functional coupling with the basal ganglia, that dopamine modulates cerebellar circuits. The failure to recruit the cerebellum in the off state of Parkinson's disease could therefore be the result of impaired basal ganglia -cerebellar coupling (Morton and Bastian, 2004; Bostan et al., 2013) . This is in accordance with previous resting state functional MRI studies showing reduced functional coupling between the striatum and the cerebellum in the dopamine depleted . Post-hoc correlation analysis between the amount of functional connectivity in the cognitive and motor cortico-striatal loops and intra-striatal limbic pathways in Parkinson's disease patients on dopaminergic replacement medication (n=23). A=Representation of the cortico-striatal and intra-striatal limbic pathways used for the analysis; B=Scatter plots for the correlations between the amount of functional connectivity between the cognitive cortico-striatal loop and intra-striatal limbic pathways; C=Scatter plots for the correlations between the amount of functional connectivity between the motor cortico-striatal loop and intra-striatal limbic pathways. NOTE: PD ON=Parkinson's disease patients on dopaminergic replacement medication; DC=Dorsal Caudate; DCP=Dorsal Caudal Putamen; VSi=Inferior Ventral Striatum; DLPFC=Dorsolateral Prefrontal Cortex; M1=Primary motor cortex of the leg area; *Indicates a significant p-value (p < 0.05) that survived Bonferonni correction for multiple comparisons.
state of Parkinson's disease (Hacker et al., 2012; Jech et al., 2013; Bell et al., 2014) .
Striatal dysfunction can lead to an over-activation of the output nuclei of the basal ganglia (e.g. subthalamic nucleus and globus pallidus internus) that send inhibitory GABAergic projections to the cerebellum (via the pontine nuclei), thus hampering cerebellar compensation abilities in Parkinson patients off medication (Lewis and Barker, 2009; Bostan et al., 2013; Lewis and Shine, 2014) . This is further evidenced by an increase in neuronal activation of deep cerebellar nuclei following high-frequency stimulation of the subthalamic nucleus in rats (Moers-Hornikx et al., 2011) and normalized cerebellar activation in patients with Parkinson's disease that received subthalamic deep brain stimulation (Asanuma et al., 2006; Grafton et al., 2006; Hill et al., 2013; Wu and Hallett, 2013) . Future studies are encouraged to further investigate these important dopamine related compensatory and pathological alterations in striatal-cerebellar and cortico-cerebellar networks during gait in Parkinson's disease (Wu and Hallett, 2013) . In addition, these results lend weight to investigating the potential therapeutic implications of non-invasive cerebellar stimulation techniques (e.g. transcranial magnetic stimulation) to improve gait in patients with Parkinson's disease (Koch et al., 2008) . The cerebellum also shares connections with the frontal and parietal cortices via the thalamus, which is also intimately involved in cortico-basal ganglia circuitry (Lewis and Barker, 2009; Bohnen and Jahn, 2013; Verlinden et al., 2016) . It is therefore somewhat surprising that the current study did not find any significant thalamic influence on step time variability. For instance, higher white matter microstructure radiations between the thalamus and cortical and cerebellar regions have recently been shown to be associated with improved gait measures, including step width variability in healthy elderly (Verlinden et al., 2016) . Future studies specifically examining thalamic-cortical connectivity as a function of motor automaticity may be more sensitive to the effects of dopamine on thalamic circuitry. In addition, it remains to be determined whether white matter changes are associated with increased gait variability in Parkinson's disease. The negative association found in the off state between step time variability and BOLD responses of the right dorsal premotor cortex and left posterior parietal cortex indicate that Parkinson's disease patients are unable to bring these brain regions online, leading to increasing step time variability. Alternatively, patients may have utilized these cortical regions as a compensatory strategy to improve their stepping performance in the off state. Future studies are now needed to test these hypotheses, as causality could not be inferred from these results.
The functional connectivity analysis revealed a significant main effect of condition where each within and between network connection significantly increased its functional connectivity during walk compared to watch, highlighting the involvement of these predefined networks in lower limb motor performance in Parkinson's disease (Lewis and Barker, 2009; Bohnen and Jahn, 2013; Hamacher et al., 2015; Wu et al., 2015; Peterson and Horak, 2016) . Furthermore, a significant main effect of medication was found within the attentional motor network, showing overall increased functional connectivity in the off state. This dopaminergic effect likely reflects the attentional compensatory strategy employed by Parkinson patients off medication as a result of impaired striatal functioning (Bohnen and Jahn, 2013; Clark, 2015; Wu et al., 2015) . Indeed, the dopaminergic innervation of the striatum significantly correlated with the effects of dopamine within the other networks, reflecting the importance of striatal dopamine in large-scale network function during lower limb movements (Kelly et al., 2009; Jech et al., 2013; Bell et al., 2014) . Furthermore, a significant condition by medication interaction effect was found within the striatum. This finding advances previous resting state functional MRI studies by showing that impaired integration across striatal subdivisions in the dopamine depleted state of Parkinson's disease found during rest also affects lower limb motor performance (Helmich et To our knowledge, this study is the first to show that impaired crosstalk across the dopaminergically-depleted striatum of Parkinson's disease correlates with increased step time variability. Furthermore, our post-hoc analyses revealed that intra-striatal limbic circuits were driving this correlation with worse step time variability. In fact, the functional connectivity within the orbitofrontal-ventral striatum limbic circuit was strongly correlated with increased step time variability in the dopamine depleted state. The current study therefore provides novel pathophysiological evidence to suggest that activation in the orbitofrontal cortex during gait in Parkinson's disease is related to activity within a limbic cortico-striatal circuit that, in the context of reduced dopamine, interferes with the striatal control of lower limb motor function.
Our findings are supported by primate work showing that the terminals of the orbitofrontal cortex are extensive throughout the dopaminergic neurons, which influence a wide area of the striatum, particularly the ventral striatum and core of the nucleus accumbens (Haber et al., 1995) . Furthermore, a resting state functional MRI study by Di Martino et al. (2008) showed that in healthy adults the spontaneous fluctuations in BOLD response in the inferior ventral striatum primarily correlated with the orbitofrontal cortex, indicating that strong functional connections exist between these regions in humans (Di Martino et al., 2008) . Yang et al. (2016) also recently showed that functional connectivity during rest was increased between the ventral striatum and orbitofrontal cortex in Parkinson's disease patients off dopaminergic medication as compared to when medication, indicating that dopamine has a profound influence on this orbitofrontal-striatal limbic circuitry (Yang et al., 2016) .
The striatal projections allow the orbitofrontal cortex to regulate motor actions under the influence of dopamine, for instance to adapt behaviour in the face of unexpected outcomes (Schoenbaum et al., 2009; Takahashi et al., 2009; Rolls, 2015) . It has previously been proposed that error signals processed by the midbrain dopaminergic neurons that project to the striatum originate within regions of the orbitofrontal cortex that encode expected value and performance outcome, and which later connect to the ventral striatum (Takahashi et al., 2011; Rolls, 2015) . The orbitofrontal cortex indeed receives negative prediction error feedback (i.e. sensory evidence that did not match the predicted performance outcome) from every sensory system, making it an important hub for multisensory integration that enables planning and learning performance outcomes (Kringelbach, 2005; Schoenbaum et al., 2009; Takahashi et al., 2009; Goble et al., 2011; Rolls, 2015; Chanes and Barrett, 2016) . As Parkinson's disease patients have known sensorimotor impairments (Nolano et al., 2008; Conte et al., 2013; Ehgoetz Martens et al., 2013; Lucas et al., 2013) , the increased BOLD responses found in the orbitofrontal cortex in the Parkinson group off medication could reflect an attempt to adapt behaviour following increased negative prediction error feedback (Kringelbach, 2005; Schoenbaum et al., 2009; Takahashi et al., 2009) . Indeed, our results further showed that increased intra-striatal limbic functional connectivity was correlated with increased functional connectivity within regions of the cognitive cortico-striatal pathway selectively in the "on" state. This might indicate that with sufficient dopaminergic resources, the striatum is able to functionally integrate limbic information into the parallel cortico-striatal pathways, which can then provide top-down control over motor performance to resolve the prediction error and prevent motor deterioration (i.e. compensation) (Postuma and Dagher, 2006; Lewis and Barker, 2009; Rolls, 2015) . However, dopamine depletion likely impairs such parallel cortico-striatal integration within the striatum, as evidenced by the lack of such correlations in "off" state (Lewis and Barker, 2009; Bell et al., 2014; Wu et al., 2015) . The prediction error would therefore remain unresolved and hence, continue to induce an increased limbic drive within the striatal network. This could impair motor performance directly by innervating the inhibitory basal ganglia output structures that project to the brainstem locomotor centres (Lewis and Barker, 2009; Lewis and Shine, 2014) . In addition, the increased limbic drive likely demands a proportion of the depleted dopaminergic resources within the striatum, further depriving the dorsal striatum from its ability to process automated motor sequences (Wu et al., 2015) . Therefore, based on the results of the current study, it can be postulated that although the ventral striatal-orbitofrontal circuit may usually be employed as a compensatory strategy to overcome negative error feedback, without sufficient dopaminergic resources utilizing this network can actually deteriorate motor performance in Parkinson's disease patients.
This study now forms the basis for future work. The orbitofrontal cortex has previously been associated with the integration of emotional information into decision processes (Bechara et al., 2000) . In addition, anxiety and depression are associated with impaired gait performance in Parkinson's disease patients (Rochester et al., 2004 (Rochester et al., , 2005 Lord et al., 2011 Lord et al., , 2013 Ehgoetz Martens et al., 2015) , and these deficits are amenable to dopaminergic medication (Ehgoetz Martens et al., 2015) . Previous authors have postulated that depression and anxiety impair goal-directed attentional processing (Rochester et al., 2004 (Rochester et al., , 2005 , possibly by increasing computational load of the ventral striatumorbitofrontal pathway resulting in response conflict in the dopamine depleted cortico-basal ganglia motor circuitry (Lewis and Barker, 2009; Ehgoetz Martens et al., 2013 . Future studies should therefore investigate the complex interaction between dopamine, mood disturbance and gait impairments in Parkinson's disease.
In addition, the current patient cohort consisted mostly of patients with moderate bilateral disease (1 subject scored HY=1; 18 subjects scored HY=2-3; 3 subjects scored HY=3 and no subjects scored HY > 3). As such, future work is needed to investigate whether the neural basis underlying gait variability changes with disease severity. Furthermore, it is recommended that future studies account for laterality in brain pathology when analysing neuroimaging data in a cohort of Parkinson's disease patients with obvious unilateral symptom severities. It is also important to note that although dopamine evidently plays a key role, gait disturbances in Parkinson's disease likely reflect a multisystem neurodegenerative disorder beyond the loss of dopaminergic neurons, especially as the disease progresses (Bohnen and Albin, 2011; Bohnen and Jahn, 2013; . For instance, prefrontal cholinergic neurons are key players in attentional control functions that may be put under increasing pressure following striatal and prefrontal deterioration in Parkinson's disease Gonzales and Smith, 2015) . Gait speed has indeed been shown to be most affected in patients with both nigrostriatal dopaminergic and cortical cholinergic denervation . Future studies using larger cohorts are now needed to investigate the role of dopaminergic, cholinergic and other neurotransmitter systems on gait automaticity impairments in Parkinson's disease and Parkinson's disease subgroups, for example Parkinson's disease patients with and without freezing of gait (Bohnen and Albin, 2011; Bohnen et al., 2014) .
Furthermore, dual task interference provides an alternative avenue to study motor automaticity impairments (Yogev et al., 2005; Kelly et al., 2012; Wu et al., 2015) . Future studies are therefore encouraged to further evaluate dual task interference to confirm that the increased step time variability seen in the Parkinson's disease patients off medication reflects reduced motor automaticity (Poldrack et al., 2005; Wu et al., 2015) . However, similar to walking and most daily behaviours, simple motor tasks such as foot tapping are usually performed automatically in healthy subjects (Wu et al., 2015) . Furthermore, once a motor task is automatic it becomes difficult to revert back to controlled behaviour (Schneider and Chein, 2003; Wu et al., 2015) . It can therefore be assumed that the performance in healthy control participants and low variability seen in Parkinson's disease patients on medication indicated a more automatic motor performance. In addition, a supplementary correlation analysis was performed between the functional connectivity values and another behavioural motor outcome of the virtual reality paradigm, namely modal footstep latency, showing no significant correlations (See Supplementary Table 4 ). This further indicates that the findings of the current study are indeed specific to step time variability and thus motor automaticity. In accordance with the findings in this study, previous behavioural research has shown that the administration of dopaminergic replacement therapy often improves step time variability in Parkinson's disease patients (Hausdorff et al., 2003a; Lord et al., 2011; Rochester et al., 2011; Bryant et al., 2016) . Furthermore, impairments in dual-task walking are also often improved by optimal dopaminergic replacement therapy (Camicioli et al., 1998; Lord et al., 2011; Elshehabi et al., 2016) . Together, this evidence suggests that dopaminergic therapy may influence gait-related neural computations through modulation of motor automaticity.
While multiple motor skills rely upon motor automaticity, in this study, step time variability was employed as a surrogate for motor automaticity in an attempt to model simple gait. Equally, however, dual task paradigms can also provide insights into the breakdown of automaticity in Parkinson's disease by loading additional attentional resources with overt task demands. Future studies are now needed to further investigate the interaction between dopamine and dual tasking ability during gait in patients with Parkinson's disease. Finally, a limitation inherent in the study of motor automaticity is that indirect surrogate measures are required. Therefore, the component processes by which dopaminergic replacement therapy improves motor skills cannot be precisely isolated. While it is hypothesized that dopamine replacement therapy exerts its major mechanism of action by improving motor automaticity in subcortical structures leading to reduced step time variability, dopamine may also modulate other sub-processes including, coordination, balance, proprioception, affective processing and cognition that may affect step time variability and motor automaticity.
In conclusion, this study showed that dopamine depletion in Parkinson's disease impairs motor automaticity by reducing striatal functioning and cerebellar compensation strategies, which lead to increased attentional motor control and excessive orbitofrontal-striatal limbic interference. 
